Final-Program-ATS-2023-AP.vp

344

WEDNESDAY • MAY 24

1119 Children With Spinal Muscular Atrophy Treated With Nusinersen/Risdiplam/ A. Chacko, Brisbane, Australia 1120 Outcomes of Children Treated With Nusinersen/Onasemnogene Abeparvovec for Pediatric Spinal Muscular Atrophy Type 1/ A. Chacko, Brisbane, Australia 1121 Do People With Congenital Central Hypoventilation Syndrome Wake Up in Response to Ventilator or Monitor Alarms?/ R. Itani, Los Angeles, CA 1122 Idiopathic Apnea in Term Newborns and Infants Under 6 Months of Age: A Multicenter Study/ J.-M. Gilardoni, Nice, France

1103 Obstructive Sleep Apnea Is Associated With Use of Assisted Ventilation Among Children With Bronchopulmonary Dysplasia Hospitalized With Respiratory Illness: A Kids’ Inpatient Database Study/ P.-Y. Tsou, Boston, MA 1104 Asthma, Atopy, and Sleep Disordered Breathing in the Pediatric Adenotonsillectomy Trial for Snoring (PATS)/ P.-Y. Tsou, Boston, MA 1105 Cardiorespiratory Coupling in Extremely Preterm Infants/ N. Krishnamurthi, Chicago, IL 1106 Sleep Disordered Breathing in Adolescents and Adults With History of Extreme Prematurity: A Pilot Study/ N.J. Sanchez Solano, Dallas, TX 1107 Nocturnal Oximetry for the Diagnosis of Obstructive Sleep Apnea Syndrome (OSAS) in Infants/ A. Moudaki, Athens, Greece 1108 Development and Validation of a Sleep-disordered Breathing Questionnaire for Infants/ G. Gupta, Ann Arbor, MI 1109 The SHOOTS Questionnaire: A Pediatric Screening Tool for Obstructive Sleep Apnea/ K. Reiling, Houston, TX 1110 Non-invasive Vision-based Pulmonary Evaluation of Sleep Disordered Breathing Through Visualization of Thermal and CO2 Flow/ S. Transue, Denver, CO 1111 The Effect of Adenotonsillectomy on Cortical Thickness and Hippocampal Subfield Volumes in Obese Adolescents With Obstructive Sleep Apnea/ H. Park, Bronx, NY 1112 Does the Rate of Weight Gain Impact the Severity of Childhood Obstructive Sleep Apnea?/ Y. Mohamad, Los Angeles, CA 1113 Identification of Children at High Risk for Obstructive Sleep Apnea: A Cluster Analysis Approach/ D. Gatt, Toronto, Canada 1114 Disparities Obstructive Sleep Apnea and Excessive Daytime Sleepiness in Latino Adolescents/ J.S. Landeo Gutierrez, San Diego, CA 1115 Polysomnography in Children With Sickle Cell Disease: Multicenter Comparative Study/ A.S. Alishlash, Birmingham, AL 1116 Obstructive Sleep Apnea Screening in Children With Asthma/ M. Sowho, Baltimore, MD 1117 Obstructive Sleep Apnea Association With Behavioral Insomnia of Childhood: Or Lack Thereof/ L. Yelov, Jerusalem, Israel 1118 Screening for Non-invasive Ventilatory Requirements in Children With Spinal Muscular Atrophy/ A. Chacko, Brisbane, Australia

BASIC • CLINICAL • TRANSLATIONAL POSTER DISCUSSION SESSION

D106 HOT OFF THE PRESSES! LATE

BREAKERS IN PULMONARY VASCULAR DISEASE

12:00 p.m. - 2:00 p.m.

Walter E. Washington Convention Center Room 151 A (Street Level)

Poster Viewing

12:00-12:45 12:45-2:00

Discussion

Chairing: K. Yuan, PhD, Boston, MA K.N. Goss, MD, Dallas, TX

N.A. Kolaitis, MD, MS, San Francisco, CA B.B. Graham, MD, San Francisco, CA 401 Seralutinib for the Treatment of Pulmonary Arterial Hypertension (PAH): Results From the Phase 2 TORREY Trial/ R.P. Frantz, Rochester, MN 402 Pulmonary Hypertension and Anastrozole (Phantom): A Randomized Clinical Trial/ S.M. Kawut, Philadelphia, PA 403 Pulmonary Pericytes in Idiopathic Pulmonary Arterial Hypertension Fail to Maintain Lung Microvascular Networks in an Organ-On-A-Chip Model/ Q. Zhang, Berlin, Germany 404 MGX292, A Novel Variant of Native Bone Morphogenetic Protein 9 (BMP9) That Lacks Osteogenic Activity, Reverses Vascular Remodelling and Pulmonary Arterial Hypertension in the Sugen-hypoxia Rat Model/ N.W. Morrell, Boston, MA

405 Unpicking the Effects of General Control

Non-depressible 2 (GCN2) Deficiency in Pulmonary Veno-Occlusive Disease/ M. Schwiening, Cambridge, United Kingdom

ATS 2023 • Washington, DC